QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

Help viewing high resolution images Return to article

Fig. 4. Survival of sympathetic neurons in absence of CREB. Immunohistochemistry with an antibody recognizing activated caspase-3 (brown) is used to analyze survival of sympathetic neurons in the SCG at E17.5, and anti-TH antibody (blue) is used to identify the region of interest in controls (A,D), Creb^-/- (B,E) and Creb^DBHCre; Crem^-/- mutants (C,F). Representative sections are shown in A-F. Red arrows indicate examples of activated caspase-3-positive cells. (G) Quantitative analysis of apoptotic cells reveals reduced levels of apoptosis in sympathetic neurons of Creb^DBHCre; Crem^-/- mutants (abbreviated as M) at E17.5 in comparison with controls (abbreviated as C). At postnatal stages P0/P2 the level of apoptosis is reduced in control pups and does not change in Creb^DBHCre; Crem^-/- mutants. (H) The size of the SCG in Creb^DBHCre; Crem^-/- mutants is similar between controls and mutants at E17.5. At P0/P2 the size of the SCG in Creb^DBHCre; Crem^-/- mutants is significantly larger than in controls. The mean±s.e.m. for both SCG in at least four to five mice of each genotype are shown. Values are considered significantly different with ^*P<0.05 and ^***P<0.001 compared with controls. Scale bar: 250 µm in A-C; 40 µm in D-F. Asterisk indicates the inner ear.

Return to article